Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gcm2
|
ENSMUSG00000021362.6 | glial cells missing homolog 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr13_41103818_41103969 | Gcm2 | 1790 | 0.248191 | -0.28 | 3.2e-02 | Click! |
chr13_41104074_41104225 | Gcm2 | 1534 | 0.285254 | -0.20 | 1.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_113828248_113829427 | 13.17 |
Scg5 |
secretogranin V |
75 |
0.97 |
chr1_42697532_42698715 | 12.29 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
2355 |
0.2 |
chr8_70119024_70120981 | 11.54 |
Ncan |
neurocan |
871 |
0.35 |
chr11_81968072_81969328 | 11.17 |
Asic2 |
acid-sensing (proton-gated) ion channel 2 |
243 |
0.91 |
chr7_121391567_121393161 | 11.14 |
Hs3st2 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 2 |
74 |
0.93 |
chr8_12396308_12397229 | 10.84 |
Gm25239 |
predicted gene, 25239 |
365 |
0.77 |
chr6_88872932_88873571 | 10.64 |
Podxl2 |
podocalyxin-like 2 |
794 |
0.47 |
chr6_8955848_8957226 | 10.59 |
Nxph1 |
neurexophilin 1 |
6861 |
0.32 |
chr2_136058799_136059736 | 10.45 |
Lamp5 |
lysosomal-associated membrane protein family, member 5 |
164 |
0.96 |
chr11_55607331_55608633 | 9.84 |
Glra1 |
glycine receptor, alpha 1 subunit |
161 |
0.96 |
chr8_11187747_11188818 | 8.94 |
Gm15418 |
predicted gene 15418 |
527 |
0.75 |
chr5_110543976_110545228 | 8.76 |
Galnt9 |
polypeptide N-acetylgalactosaminyltransferase 9 |
247 |
0.9 |
chr7_78882466_78883900 | 8.39 |
Mir7-2 |
microRNA 7-2 |
5094 |
0.13 |
chr1_9298603_9300104 | 8.05 |
Sntg1 |
syntrophin, gamma 1 |
71 |
0.97 |
chr10_80298461_80300404 | 7.98 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
341 |
0.69 |
chr11_84520959_84524590 | 7.93 |
Lhx1 |
LIM homeobox protein 1 |
63 |
0.97 |
chr19_6418703_6419936 | 7.75 |
Nrxn2 |
neurexin II |
554 |
0.44 |
chr16_72027587_72029370 | 7.67 |
Gm49667 |
predicted gene, 49667 |
149434 |
0.04 |
chr3_102011198_102013204 | 7.66 |
Nhlh2 |
nescient helix loop helix 2 |
2046 |
0.32 |
chr13_83715222_83716973 | 7.64 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
5284 |
0.15 |
chr8_119447111_119447961 | 7.62 |
Necab2 |
N-terminal EF-hand calcium binding protein 2 |
817 |
0.56 |
chr8_123410787_123412789 | 7.46 |
Tubb3 |
tubulin, beta 3 class III |
198 |
0.84 |
chr3_114904046_114905354 | 7.46 |
Olfm3 |
olfactomedin 3 |
65 |
0.98 |
chr7_44336079_44337576 | 7.44 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
811 |
0.34 |
chr5_116590520_116593206 | 7.34 |
Srrm4 |
serine/arginine repetitive matrix 4 |
46 |
0.98 |
chr5_111425949_111427685 | 7.10 |
Gm43119 |
predicted gene 43119 |
3228 |
0.22 |
chr6_110646867_110647408 | 6.99 |
Gm20387 |
predicted gene 20387 |
1221 |
0.44 |
chr18_82405647_82407688 | 6.95 |
Galr1 |
galanin receptor 1 |
110 |
0.96 |
chrX_143518219_143519318 | 6.67 |
Pak3 |
p21 (RAC1) activated kinase 3 |
70 |
0.98 |
chr8_92359084_92360805 | 6.50 |
Irx5 |
Iroquois homeobox 5 |
2195 |
0.28 |
chr11_33842610_33843965 | 6.42 |
Kcnip1 |
Kv channel-interacting protein 1 |
174 |
0.97 |
chrX_101301762_101302890 | 6.39 |
Nlgn3 |
neuroligin 3 |
1852 |
0.2 |
chr4_148286849_148288201 | 6.36 |
Disp3 |
dispatched RND transporter family member 3 |
440 |
0.81 |
chr10_80300884_80302968 | 6.36 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
106 |
0.9 |
chr2_32741082_32742388 | 6.36 |
Sh2d3c |
SH2 domain containing 3C |
243 |
0.72 |
chr14_57132708_57133925 | 6.33 |
Gjb6 |
gap junction protein, beta 6 |
35 |
0.97 |
chr15_25754177_25754669 | 6.32 |
Myo10 |
myosin X |
1444 |
0.48 |
chr5_112227269_112228017 | 6.32 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
998 |
0.41 |
chr5_37248332_37249378 | 6.31 |
Crmp1 |
collapsin response mediator protein 1 |
1570 |
0.39 |
chrX_152643367_152644550 | 6.30 |
Shroom2 |
shroom family member 2 |
34 |
0.98 |
chr6_127766683_127768449 | 6.27 |
Gm42738 |
predicted gene 42738 |
24 |
0.95 |
chr6_125361206_125362192 | 6.21 |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
1272 |
0.34 |
chr10_33623738_33624906 | 6.12 |
Gm15939 |
predicted gene 15939 |
76 |
0.56 |
chr6_80019260_80020204 | 6.12 |
Lrrtm4 |
leucine rich repeat transmembrane neuronal 4 |
89 |
0.97 |
chr10_81229656_81230911 | 6.09 |
Atcay |
ataxia, cerebellar, Cayman type |
502 |
0.53 |
chr4_110285468_110287125 | 6.01 |
Elavl4 |
ELAV like RNA binding protein 4 |
320 |
0.94 |
chr3_55242295_55243824 | 6.01 |
Dclk1 |
doublecortin-like kinase 1 |
533 |
0.78 |
chr13_83726534_83727321 | 5.99 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
1179 |
0.35 |
chr12_117153278_117156362 | 5.98 |
Gm10421 |
predicted gene 10421 |
3169 |
0.37 |
chr5_116589538_116590511 | 5.95 |
Srrm4 |
serine/arginine repetitive matrix 4 |
1793 |
0.34 |
chr15_25754845_25755428 | 5.93 |
Myo10 |
myosin X |
2157 |
0.37 |
chr16_96280491_96281572 | 5.92 |
B3galt5 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 |
233 |
0.93 |
chr4_140245362_140247262 | 5.91 |
Igsf21 |
immunoglobulin superfamily, member 21 |
472 |
0.85 |
chr6_136170568_136170996 | 5.90 |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
1107 |
0.5 |
chr4_22486897_22487389 | 5.87 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
1223 |
0.42 |
chr2_25877424_25878675 | 5.79 |
Kcnt1 |
potassium channel, subfamily T, member 1 |
168 |
0.93 |
chr13_36729599_36730738 | 5.75 |
Nrn1 |
neuritin 1 |
500 |
0.75 |
chr5_138275220_138276850 | 5.75 |
Gpc2 |
glypican 2 (cerebroglycan) |
2202 |
0.11 |
chr17_57086961_57087951 | 5.73 |
Tubb4a |
tubulin, beta 4A class IVA |
326 |
0.73 |
chr18_23038815_23040349 | 5.73 |
Nol4 |
nucleolar protein 4 |
496 |
0.88 |
chr4_32862939_32864770 | 5.69 |
Ankrd6 |
ankyrin repeat domain 6 |
3171 |
0.24 |
chr10_73099097_73100287 | 5.69 |
Pcdh15 |
protocadherin 15 |
239 |
0.94 |
chr14_66344363_66345813 | 5.69 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chr8_70486586_70487634 | 5.68 |
Tmem59l |
transmembrane protein 59-like |
214 |
0.81 |
chr14_64588312_64589438 | 5.68 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
341 |
0.81 |
chr5_120433178_120434996 | 5.62 |
Gm27199 |
predicted gene 27199 |
2320 |
0.19 |
chr14_67236008_67239452 | 5.62 |
Ebf2 |
early B cell factor 2 |
3086 |
0.21 |
chr10_120564701_120565278 | 5.59 |
Gm24298 |
predicted gene, 24298 |
40548 |
0.14 |
chr3_31309226_31310664 | 5.57 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
433 |
0.72 |
chr13_42709652_42710400 | 5.55 |
Phactr1 |
phosphatase and actin regulator 1 |
445 |
0.88 |
chr3_54155686_54157140 | 5.55 |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
40 |
0.99 |
chr17_28040550_28042470 | 5.53 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
227 |
0.89 |
chr15_76519928_76521866 | 5.49 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr6_126739477_126740745 | 5.49 |
Kcna6 |
potassium voltage-gated channel, shaker-related, subfamily, member 6 |
40 |
0.97 |
chr11_116919008_116919761 | 5.48 |
Mgat5b |
mannoside acetylglucosaminyltransferase 5, isoenzyme B |
521 |
0.75 |
chr7_48960076_48960785 | 5.48 |
Nav2 |
neuron navigator 2 |
1333 |
0.41 |
chr11_54303826_54304909 | 5.47 |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
165 |
0.94 |
chr12_117688775_117690161 | 5.46 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
512 |
0.83 |
chr17_55986138_55987186 | 5.46 |
Fsd1 |
fibronectin type 3 and SPRY domain-containing protein |
147 |
0.89 |
chrX_135210129_135210918 | 5.43 |
Tceal6 |
transcription elongation factor A (SII)-like 6 |
164 |
0.93 |
chr8_110167330_110168575 | 5.39 |
Calb2 |
calbindin 2 |
254 |
0.91 |
chr2_65932868_65933620 | 5.38 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
1379 |
0.47 |
chr7_89632223_89633470 | 5.37 |
Me3 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
40 |
0.79 |
chr13_84344773_84345437 | 5.31 |
Gm26927 |
predicted gene, 26927 |
4992 |
0.25 |
chr6_8949544_8950237 | 5.31 |
Nxph1 |
neurexophilin 1 |
214 |
0.97 |
chr2_18042311_18043883 | 5.30 |
Skida1 |
SKI/DACH domain containing 1 |
1475 |
0.25 |
chr3_80800286_80803016 | 5.29 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
928 |
0.67 |
chr2_181155937_181157234 | 5.28 |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
429 |
0.73 |
chr9_103112101_103112762 | 5.27 |
Rab6b |
RAB6B, member RAS oncogene family |
624 |
0.68 |
chr12_87026152_87027307 | 5.25 |
Tmem63c |
transmembrane protein 63c |
113 |
0.95 |
chr6_112945034_112945954 | 5.25 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
1260 |
0.31 |
chr10_92162169_92163486 | 5.25 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
66 |
0.98 |
chr14_52310870_52313267 | 5.24 |
Sall2 |
spalt like transcription factor 2 |
4255 |
0.1 |
chr19_6499251_6500132 | 5.24 |
Nrxn2 |
neurexin II |
1856 |
0.23 |
chr18_80984086_80984990 | 5.24 |
Sall3 |
spalt like transcription factor 3 |
1998 |
0.23 |
chr5_90758918_90760166 | 5.19 |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
164 |
0.91 |
chr13_18948406_18949248 | 5.18 |
Amph |
amphiphysin |
429 |
0.8 |
chr19_6498687_6498960 | 5.18 |
Nrxn2 |
neurexin II |
988 |
0.42 |
chr4_129985171_129986191 | 5.16 |
Adgrb2 |
adhesion G protein-coupled receptor B2 |
413 |
0.79 |
chr15_89453545_89454765 | 5.15 |
Mapk8ip2 |
mitogen-activated protein kinase 8 interacting protein 2 |
242 |
0.82 |
chr8_122335750_122336915 | 5.15 |
Zfpm1 |
zinc finger protein, multitype 1 |
1701 |
0.24 |
chr2_158610228_158611991 | 5.12 |
Slc32a1 |
solute carrier family 32 (GABA vesicular transporter), member 1 |
342 |
0.44 |
chr13_83732205_83734272 | 5.11 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
672 |
0.58 |
chr4_127988222_127989180 | 5.10 |
Csmd2 |
CUB and Sushi multiple domains 2 |
657 |
0.77 |
chr7_4119233_4120703 | 5.10 |
Ttyh1 |
tweety family member 1 |
214 |
0.7 |
chr7_119184137_119185474 | 5.09 |
Gpr139 |
G protein-coupled receptor 139 |
202 |
0.96 |
chr3_89243498_89245184 | 5.08 |
Trim46 |
tripartite motif-containing 46 |
672 |
0.36 |
chr9_45432313_45432910 | 5.06 |
4833428L15Rik |
RIKEN cDNA 4833428L15 gene |
881 |
0.47 |
chr5_63649182_63650439 | 5.06 |
Gm9954 |
predicted gene 9954 |
454 |
0.49 |
chr18_42394146_42396205 | 5.06 |
Pou4f3 |
POU domain, class 4, transcription factor 3 |
100 |
0.97 |
chr11_108926426_108927821 | 5.05 |
Axin2 |
axin 2 |
3942 |
0.24 |
chr1_120604474_120605877 | 5.05 |
En1 |
engrailed 1 |
2757 |
0.3 |
chr3_27371157_27372632 | 5.05 |
Ghsr |
growth hormone secretagogue receptor |
543 |
0.81 |
chr5_37245879_37246957 | 5.04 |
Crmp1 |
collapsin response mediator protein 1 |
573 |
0.76 |
chr1_135583494_135584229 | 5.01 |
Gm4793 |
predicted gene 4793 |
912 |
0.48 |
chr7_82869041_82870364 | 4.97 |
Mex3b |
mex3 RNA binding family member B |
2369 |
0.22 |
chr15_87544354_87545329 | 4.97 |
Tafa5 |
TAFA chemokine like family member 5 |
542 |
0.87 |
chr11_19015600_19017063 | 4.96 |
Meis1 |
Meis homeobox 1 |
42 |
0.96 |
chr7_44428985_44430475 | 4.95 |
Lrrc4b |
leucine rich repeat containing 4B |
712 |
0.43 |
chr7_45785390_45787192 | 4.94 |
Lmtk3 |
lemur tyrosine kinase 3 |
266 |
0.77 |
chr1_172484027_172485046 | 4.93 |
Igsf9 |
immunoglobulin superfamily, member 9 |
2222 |
0.17 |
chr5_144545163_144547007 | 4.91 |
Nptx2 |
neuronal pentraxin 2 |
183 |
0.96 |
chr14_93888035_93888426 | 4.91 |
Pcdh9 |
protocadherin 9 |
502 |
0.87 |
chr15_83780142_83780827 | 4.90 |
Mpped1 |
metallophosphoesterase domain containing 1 |
461 |
0.86 |
chr1_42703141_42704653 | 4.89 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4155 |
0.16 |
chr2_143547529_143548278 | 4.86 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
66 |
0.97 |
chr2_157914223_157915670 | 4.85 |
Vstm2l |
V-set and transmembrane domain containing 2-like |
293 |
0.91 |
chr15_81936444_81938042 | 4.80 |
Csdc2 |
cold shock domain containing C2, RNA binding |
261 |
0.82 |
chr1_166308788_166309685 | 4.80 |
5330438I03Rik |
RIKEN cDNA 5330438I03 gene |
349 |
0.87 |
chrX_73503094_73503593 | 4.78 |
Atp2b3 |
ATPase, Ca++ transporting, plasma membrane 3 |
257 |
0.88 |
chr13_51594475_51595717 | 4.78 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
25609 |
0.16 |
chr5_128952013_128953618 | 4.75 |
Rimbp2 |
RIMS binding protein 2 |
218 |
0.95 |
chr15_89532557_89533956 | 4.75 |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
366 |
0.78 |
chr10_57784547_57786586 | 4.75 |
Fabp7 |
fatty acid binding protein 7, brain |
643 |
0.68 |
chr1_18057820_18058958 | 4.74 |
Gm45784 |
predicted gene 45784 |
120 |
0.8 |
chr11_118908287_118909561 | 4.74 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
626 |
0.73 |
chr4_155042413_155043778 | 4.74 |
Plch2 |
phospholipase C, eta 2 |
59 |
0.94 |
chr8_36548328_36549520 | 4.71 |
Dlc1 |
deleted in liver cancer 1 |
28345 |
0.19 |
chr5_128432188_128433399 | 4.70 |
Tmem132d |
transmembrane protein 132D |
284 |
0.89 |
chr16_9993943_9994361 | 4.67 |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
118 |
0.97 |
chr2_181715341_181715994 | 4.66 |
Oprl1 |
opioid receptor-like 1 |
35 |
0.95 |
chr7_5056231_5057716 | 4.66 |
Gm15510 |
predicted gene 15510 |
53 |
0.48 |
chrX_170674573_170675954 | 4.66 |
Asmt |
acetylserotonin O-methyltransferase |
2619 |
0.41 |
chr8_12947702_12949640 | 4.65 |
Mcf2l |
mcf.2 transforming sequence-like |
718 |
0.37 |
chr5_117242536_117243323 | 4.65 |
Taok3 |
TAO kinase 3 |
2469 |
0.22 |
chr7_126952524_126952951 | 4.64 |
Sez6l2 |
seizure related 6 homolog like 2 |
1130 |
0.2 |
chr6_121472749_121474141 | 4.64 |
Iqsec3 |
IQ motif and Sec7 domain 3 |
178 |
0.95 |
chr8_87469746_87471270 | 4.64 |
Cbln1 |
cerebellin 1 precursor protein |
560 |
0.63 |
chr4_46990869_46991621 | 4.62 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
628 |
0.7 |
chr9_107706739_107707764 | 4.61 |
Sema3f |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
1695 |
0.2 |
chr11_71750709_71751963 | 4.59 |
Wscd1 |
WSC domain containing 1 |
40 |
0.97 |
chr13_58806621_58807262 | 4.57 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
302 |
0.85 |
chr7_126274826_126275043 | 4.56 |
Sbk1 |
SH3-binding kinase 1 |
1534 |
0.28 |
chr7_25180336_25182324 | 4.56 |
Pou2f2 |
POU domain, class 2, transcription factor 2 |
1604 |
0.22 |
chr2_181313043_181314281 | 4.55 |
Stmn3 |
stathmin-like 3 |
838 |
0.42 |
chr5_9724633_9726223 | 4.54 |
Grm3 |
glutamate receptor, metabotropic 3 |
258 |
0.93 |
chr9_91369028_91370469 | 4.54 |
Zic4 |
zinc finger protein of the cerebellum 4 |
250 |
0.86 |
chr19_5093987_5095591 | 4.53 |
Cnih2 |
cornichon family AMPA receptor auxiliary protein 2 |
3593 |
0.08 |
chr11_107914254_107915311 | 4.52 |
Cacng5 |
calcium channel, voltage-dependent, gamma subunit 5 |
273 |
0.91 |
chrX_136590440_136591154 | 4.51 |
Tceal3 |
transcription elongation factor A (SII)-like 3 |
45 |
0.96 |
chr18_89768830_89769936 | 4.51 |
Dok6 |
docking protein 6 |
145 |
0.97 |
chr5_130448513_130449808 | 4.51 |
Caln1 |
calneuron 1 |
359 |
0.91 |
chr15_98003545_98005314 | 4.51 |
Col2a1 |
collagen, type II, alpha 1 |
62 |
0.97 |
chrX_101300806_101301090 | 4.51 |
Nlgn3 |
neuroligin 3 |
474 |
0.67 |
chr12_61523440_61524787 | 4.50 |
Lrfn5 |
leucine rich repeat and fibronectin type III domain containing 5 |
165 |
0.95 |
chr4_91380440_91381612 | 4.50 |
Elavl2 |
ELAV like RNA binding protein 1 |
4530 |
0.22 |
chr18_45559502_45560715 | 4.49 |
Gm31907 |
predicted gene, 31907 |
22 |
0.51 |
chr3_87947557_87949450 | 4.47 |
Crabp2 |
cellular retinoic acid binding protein II |
163 |
0.9 |
chr19_22138603_22139842 | 4.47 |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
105 |
0.98 |
chr7_79052729_79053830 | 4.47 |
Gm26633 |
predicted gene, 26633 |
44 |
0.71 |
chr7_140080531_140082545 | 4.44 |
Caly |
calcyon neuron-specific vesicular protein |
689 |
0.48 |
chr12_5373829_5374490 | 4.43 |
Klhl29 |
kelch-like 29 |
1523 |
0.37 |
chr2_136713069_136714459 | 4.43 |
Snap25 |
synaptosomal-associated protein 25 |
286 |
0.92 |
chr6_113501346_113502215 | 4.42 |
Prrt3 |
proline-rich transmembrane protein 3 |
38 |
0.94 |
chr5_117492934_117494252 | 4.42 |
Gm42550 |
predicted gene 42550 |
27106 |
0.18 |
chr5_120430812_120431653 | 4.42 |
Lhx5 |
LIM homeobox protein 5 |
467 |
0.48 |
chr8_109250884_109251908 | 4.41 |
D030068K23Rik |
RIKEN cDNA D030068K23 gene |
1530 |
0.52 |
chr11_6604576_6606131 | 4.41 |
Nacad |
NAC alpha domain containing |
700 |
0.46 |
chr7_64501626_64502920 | 4.41 |
Apba2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
135 |
0.96 |
chr7_46399823_46400899 | 4.41 |
Kcnc1 |
potassium voltage gated channel, Shaw-related subfamily, member 1 |
2713 |
0.23 |
chr1_124045018_124046369 | 4.40 |
Dpp10 |
dipeptidylpeptidase 10 |
134 |
0.98 |
chr13_44843445_44844028 | 4.38 |
Jarid2 |
jumonji, AT rich interactive domain 2 |
2953 |
0.28 |
chr1_194622071_194623282 | 4.37 |
Plxna2 |
plexin A2 |
2851 |
0.26 |
chr5_128602323_128602997 | 4.37 |
Fzd10 |
frizzled class receptor 10 |
1816 |
0.25 |
chr3_88458101_88459325 | 4.36 |
Sema4a |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
163 |
0.88 |
chr3_88218283_88218537 | 4.33 |
Gm25641 |
predicted gene, 25641 |
2714 |
0.1 |
chr7_3390544_3391386 | 4.33 |
Cacng8 |
calcium channel, voltage-dependent, gamma subunit 8 |
282 |
0.73 |
chr16_42339015_42340584 | 4.33 |
Gap43 |
growth associated protein 43 |
852 |
0.7 |
chr13_72629730_72632045 | 4.32 |
Irx2 |
Iroquois homeobox 2 |
1062 |
0.51 |
chr8_121730928_121732115 | 4.32 |
Jph3 |
junctophilin 3 |
954 |
0.49 |
chr4_22487396_22488284 | 4.31 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
526 |
0.73 |
chr7_25004827_25006284 | 4.31 |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
340 |
0.79 |
chr4_126465012_126466992 | 4.31 |
Ago1 |
argonaute RISC catalytic subunit 1 |
2419 |
0.18 |
chr5_108549212_108550612 | 4.31 |
Cplx1 |
complexin 1 |
88 |
0.95 |
chr1_109982396_109983459 | 4.31 |
Cdh7 |
cadherin 7, type 2 |
54 |
0.99 |
chrX_169827749_169828991 | 4.30 |
Mid1 |
midline 1 |
211 |
0.96 |
chr13_34133417_34134151 | 4.28 |
Gm36500 |
predicted gene, 36500 |
76 |
0.95 |
chr15_98674837_98676155 | 4.28 |
Rnd1 |
Rho family GTPase 1 |
1962 |
0.18 |
chr10_69536011_69536410 | 4.28 |
Ank3 |
ankyrin 3, epithelial |
1988 |
0.39 |
chr17_24689022_24690262 | 4.27 |
Syngr3 |
synaptogyrin 3 |
313 |
0.69 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 16.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
5.1 | 15.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
4.6 | 18.5 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
4.5 | 26.8 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
4.1 | 20.7 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
3.6 | 10.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
3.3 | 3.3 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
3.3 | 9.8 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
3.2 | 9.6 | GO:0033058 | directional locomotion(GO:0033058) |
2.9 | 11.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
2.9 | 28.8 | GO:0060013 | righting reflex(GO:0060013) |
2.8 | 5.7 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.8 | 8.5 | GO:0061642 | chemoattraction of axon(GO:0061642) |
2.8 | 8.5 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
2.8 | 11.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
2.8 | 8.3 | GO:0021586 | pons maturation(GO:0021586) |
2.7 | 22.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
2.6 | 13.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
2.5 | 7.5 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
2.5 | 7.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.4 | 12.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
2.4 | 7.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
2.4 | 2.4 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
2.4 | 4.8 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
2.3 | 4.7 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
2.3 | 9.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
2.3 | 11.5 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
2.3 | 4.5 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
2.2 | 9.0 | GO:0007412 | axon target recognition(GO:0007412) |
2.2 | 4.5 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
2.2 | 6.7 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
2.2 | 2.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
2.2 | 4.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
2.1 | 6.4 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
2.1 | 8.5 | GO:0030035 | microspike assembly(GO:0030035) |
2.1 | 2.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
2.1 | 10.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
2.1 | 10.4 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
2.1 | 6.2 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
2.1 | 6.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
2.1 | 12.4 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
2.1 | 2.1 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
2.1 | 6.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
2.0 | 6.0 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
2.0 | 7.9 | GO:0006551 | leucine metabolic process(GO:0006551) |
2.0 | 9.8 | GO:0071625 | vocalization behavior(GO:0071625) |
2.0 | 7.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.9 | 5.8 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
1.9 | 5.8 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.9 | 3.8 | GO:0051795 | positive regulation of catagen(GO:0051795) |
1.9 | 15.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
1.9 | 1.9 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
1.9 | 1.9 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.9 | 29.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.8 | 9.2 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
1.8 | 3.6 | GO:0060166 | olfactory pit development(GO:0060166) |
1.8 | 3.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.8 | 14.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.8 | 9.0 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.8 | 3.6 | GO:0060594 | mammary gland specification(GO:0060594) |
1.8 | 3.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.8 | 25.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
1.8 | 10.7 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.8 | 14.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.8 | 1.8 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
1.8 | 1.8 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
1.8 | 7.1 | GO:0061743 | motor learning(GO:0061743) |
1.7 | 8.7 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.7 | 5.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.7 | 3.5 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.7 | 25.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.7 | 1.7 | GO:0061317 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
1.7 | 6.8 | GO:0060174 | limb bud formation(GO:0060174) |
1.7 | 32.0 | GO:0001964 | startle response(GO:0001964) |
1.7 | 5.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
1.7 | 6.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.7 | 5.0 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.7 | 1.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.7 | 14.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.6 | 1.6 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.6 | 4.9 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.6 | 12.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.6 | 3.2 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.6 | 3.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.6 | 4.8 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
1.6 | 1.6 | GO:2000040 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
1.6 | 3.2 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
1.6 | 3.2 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.6 | 4.7 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
1.6 | 3.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
1.5 | 6.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.5 | 4.5 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
1.5 | 3.0 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.5 | 4.5 | GO:0010996 | response to auditory stimulus(GO:0010996) |
1.4 | 2.9 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.4 | 4.3 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
1.4 | 75.5 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.4 | 2.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.4 | 14.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.4 | 4.2 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
1.4 | 4.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.3 | 2.7 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.3 | 4.0 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
1.3 | 4.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.3 | 2.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.3 | 2.6 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
1.3 | 5.2 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.3 | 6.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.3 | 3.9 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
1.3 | 2.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
1.3 | 9.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
1.3 | 10.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.3 | 2.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
1.2 | 5.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.2 | 3.7 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
1.2 | 4.9 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.2 | 2.5 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.2 | 1.2 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
1.2 | 2.5 | GO:0009629 | response to gravity(GO:0009629) |
1.2 | 1.2 | GO:0015744 | succinate transport(GO:0015744) |
1.2 | 6.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.2 | 1.2 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
1.2 | 12.0 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
1.2 | 1.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
1.2 | 15.5 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
1.2 | 3.6 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.2 | 1.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.2 | 3.5 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.2 | 2.3 | GO:0070253 | somatostatin secretion(GO:0070253) |
1.2 | 7.0 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
1.2 | 6.9 | GO:0048840 | otolith development(GO:0048840) |
1.1 | 2.3 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
1.1 | 5.7 | GO:0070842 | aggresome assembly(GO:0070842) |
1.1 | 6.8 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
1.1 | 4.5 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.1 | 3.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.1 | 3.3 | GO:0097503 | sialylation(GO:0097503) |
1.1 | 18.9 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
1.1 | 1.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.1 | 3.3 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
1.1 | 3.3 | GO:0035907 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
1.1 | 1.1 | GO:0021544 | subpallium development(GO:0021544) |
1.1 | 2.2 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
1.1 | 1.1 | GO:0072174 | metanephric tubule formation(GO:0072174) |
1.1 | 5.4 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
1.1 | 19.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.1 | 3.2 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
1.1 | 3.2 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.1 | 4.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
1.1 | 3.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.1 | 3.2 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.0 | 3.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.0 | 4.2 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.0 | 4.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
1.0 | 4.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
1.0 | 1.0 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.0 | 4.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.0 | 7.1 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
1.0 | 2.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
1.0 | 1.0 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
1.0 | 3.0 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
1.0 | 3.0 | GO:0015817 | histidine transport(GO:0015817) |
1.0 | 3.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.0 | 2.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.0 | 2.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.0 | 3.9 | GO:0050955 | thermoception(GO:0050955) |
1.0 | 4.9 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
1.0 | 1.0 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.0 | 4.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.0 | 72.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.0 | 4.8 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.0 | 1.9 | GO:0046958 | nonassociative learning(GO:0046958) |
0.9 | 11.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.9 | 1.9 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.9 | 2.8 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.9 | 2.8 | GO:0015755 | fructose transport(GO:0015755) |
0.9 | 4.6 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.9 | 2.8 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.9 | 28.6 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.9 | 3.7 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.9 | 6.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.9 | 2.7 | GO:0060437 | lung growth(GO:0060437) |
0.9 | 3.7 | GO:0003139 | secondary heart field specification(GO:0003139) |
0.9 | 0.9 | GO:0060026 | convergent extension(GO:0060026) |
0.9 | 7.2 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.9 | 1.8 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.9 | 1.8 | GO:0014028 | notochord formation(GO:0014028) |
0.9 | 0.9 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.9 | 1.8 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.9 | 7.0 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.9 | 1.7 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.9 | 1.7 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.9 | 3.5 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.9 | 0.9 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.9 | 0.9 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.9 | 2.6 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.9 | 0.9 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.9 | 2.6 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.9 | 2.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.9 | 3.4 | GO:0072044 | collecting duct development(GO:0072044) |
0.8 | 2.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.8 | 4.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.8 | 0.8 | GO:0070384 | Harderian gland development(GO:0070384) |
0.8 | 3.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.8 | 4.1 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.8 | 2.5 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.8 | 2.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.8 | 2.4 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.8 | 2.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.8 | 2.4 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.8 | 1.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.8 | 3.2 | GO:0022038 | corpus callosum development(GO:0022038) |
0.8 | 1.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.8 | 4.7 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.8 | 4.7 | GO:0030432 | peristalsis(GO:0030432) |
0.8 | 13.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.8 | 0.8 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.8 | 16.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.8 | 39.2 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.8 | 6.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.8 | 6.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.8 | 1.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.8 | 2.3 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.8 | 3.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.8 | 0.8 | GO:0031620 | regulation of fever generation(GO:0031620) |
0.8 | 2.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.7 | 0.7 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.7 | 3.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.7 | 0.7 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.7 | 2.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.7 | 1.5 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.7 | 0.7 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.7 | 1.4 | GO:0001757 | somite specification(GO:0001757) |
0.7 | 1.4 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.7 | 2.2 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.7 | 2.1 | GO:0060073 | micturition(GO:0060073) |
0.7 | 5.0 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.7 | 1.4 | GO:0008355 | olfactory learning(GO:0008355) |
0.7 | 2.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.7 | 0.7 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.7 | 1.4 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.7 | 1.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.7 | 4.9 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.7 | 1.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.7 | 54.0 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.7 | 2.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.7 | 7.6 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.7 | 4.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.7 | 4.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.7 | 0.7 | GO:0021546 | rhombomere development(GO:0021546) |
0.7 | 0.7 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.7 | 2.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.7 | 7.4 | GO:0060384 | innervation(GO:0060384) |
0.7 | 0.7 | GO:0060278 | regulation of ovulation(GO:0060278) |
0.7 | 2.7 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.7 | 0.7 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.7 | 1.3 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.7 | 2.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.7 | 6.5 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.6 | 1.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.6 | 2.6 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.6 | 1.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.6 | 1.9 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.6 | 3.2 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.6 | 1.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.6 | 1.9 | GO:0015888 | thiamine transport(GO:0015888) |
0.6 | 1.9 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.6 | 0.6 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.6 | 1.2 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.6 | 2.5 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.6 | 1.8 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.6 | 0.6 | GO:0050957 | equilibrioception(GO:0050957) |
0.6 | 13.3 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.6 | 1.8 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.6 | 1.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.6 | 4.8 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.6 | 3.0 | GO:0035640 | exploration behavior(GO:0035640) |
0.6 | 7.2 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.6 | 0.6 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.6 | 1.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.6 | 0.6 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.6 | 1.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.6 | 4.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 4.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.6 | 1.7 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.6 | 1.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.6 | 2.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.6 | 1.7 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.6 | 0.6 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.6 | 3.9 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.6 | 5.1 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.6 | 0.6 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.6 | 1.1 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.6 | 7.8 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.6 | 1.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.6 | 1.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.6 | 1.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.5 | 3.8 | GO:0015824 | proline transport(GO:0015824) |
0.5 | 1.6 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.5 | 2.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.5 | 1.6 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.5 | 16.9 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.5 | 0.5 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.5 | 2.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.5 | 0.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.5 | 3.3 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.5 | 2.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.5 | 2.7 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.5 | 0.5 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
0.5 | 1.6 | GO:0007619 | courtship behavior(GO:0007619) |
0.5 | 1.6 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.5 | 2.6 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.5 | 3.1 | GO:0007614 | short-term memory(GO:0007614) |
0.5 | 0.5 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
0.5 | 1.6 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.5 | 1.5 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.5 | 7.6 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.5 | 2.0 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.5 | 3.5 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.5 | 4.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.5 | 1.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.5 | 0.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.5 | 25.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.5 | 1.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 1.5 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.5 | 1.0 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.5 | 0.5 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.5 | 0.5 | GO:0090427 | activation of meiosis(GO:0090427) |
0.5 | 1.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.5 | 5.3 | GO:0036065 | fucosylation(GO:0036065) |
0.5 | 1.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.5 | 0.5 | GO:0072553 | terminal button organization(GO:0072553) |
0.5 | 2.4 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
0.5 | 2.4 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.5 | 1.4 | GO:0015816 | glycine transport(GO:0015816) |
0.5 | 5.7 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.5 | 1.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.5 | 0.5 | GO:0051593 | response to folic acid(GO:0051593) |
0.5 | 0.9 | GO:0097061 | dendritic spine organization(GO:0097061) |
0.5 | 1.4 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.5 | 0.5 | GO:0043584 | nose development(GO:0043584) |
0.5 | 1.8 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.5 | 8.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.5 | 1.4 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.5 | 0.9 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.5 | 1.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.5 | 4.5 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.5 | 11.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.5 | 0.5 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.5 | 1.4 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.4 | 0.9 | GO:0014075 | response to amphetamine(GO:0001975) response to amine(GO:0014075) |
0.4 | 1.8 | GO:0001927 | exocyst assembly(GO:0001927) |
0.4 | 12.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.4 | 1.3 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.4 | 1.3 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.4 | 1.3 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.4 | 0.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.4 | 3.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.4 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.4 | 1.3 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.4 | 7.1 | GO:0021766 | hippocampus development(GO:0021766) |
0.4 | 1.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.4 | 1.3 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.4 | 2.2 | GO:0032095 | regulation of response to food(GO:0032095) |
0.4 | 0.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.4 | 0.4 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.4 | 1.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.4 | 1.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.4 | 1.3 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.4 | 0.9 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.4 | 2.5 | GO:0015846 | polyamine transport(GO:0015846) |
0.4 | 1.7 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.4 | 2.1 | GO:0015884 | folic acid transport(GO:0015884) |
0.4 | 1.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.4 | 2.5 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.4 | 3.0 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.4 | 2.1 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.4 | 0.8 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.4 | 0.8 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.4 | 2.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.4 | 0.4 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.4 | 0.8 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.4 | 0.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.4 | 0.8 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.4 | 2.4 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.4 | 2.8 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.4 | 0.8 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.4 | 2.4 | GO:0032094 | response to food(GO:0032094) |
0.4 | 2.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 1.6 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.4 | 1.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.4 | 0.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 1.6 | GO:0030091 | protein repair(GO:0030091) |
0.4 | 3.5 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.4 | 3.5 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.4 | 1.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.4 | 1.9 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.4 | 1.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.4 | 0.8 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.4 | 6.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.4 | 0.4 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.4 | 4.6 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.4 | 1.1 | GO:0015819 | lysine transport(GO:0015819) |
0.4 | 5.3 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.4 | 1.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.4 | 4.9 | GO:0007616 | long-term memory(GO:0007616) |
0.4 | 1.1 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.4 | 1.1 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.4 | 3.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.4 | 5.8 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.4 | 0.7 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.4 | 23.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.4 | 0.7 | GO:0007632 | visual behavior(GO:0007632) |
0.4 | 0.7 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.4 | 0.7 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.4 | 0.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.4 | 0.7 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.4 | 1.4 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 1.4 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.3 | 0.7 | GO:0048664 | neuron fate determination(GO:0048664) |
0.3 | 1.0 | GO:0015747 | urate transport(GO:0015747) |
0.3 | 1.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.3 | 1.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.3 | 0.3 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) |
0.3 | 0.7 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.3 | 2.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.3 | 1.0 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.3 | 2.7 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.3 | 3.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.3 | 1.0 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.3 | 1.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.3 | 0.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 8.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.3 | 3.3 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 1.6 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.3 | 9.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.3 | 0.6 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.3 | 14.8 | GO:0007612 | learning(GO:0007612) |
0.3 | 1.0 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.3 | 3.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.3 | 1.3 | GO:0043084 | penile erection(GO:0043084) |
0.3 | 1.3 | GO:0042756 | drinking behavior(GO:0042756) |
0.3 | 0.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 0.6 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.3 | 1.9 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.3 | 0.6 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.3 | 0.6 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 0.3 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.3 | 0.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 0.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 0.3 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.3 | 0.3 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 0.3 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.3 | 1.8 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 1.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.3 | 0.6 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.3 | 2.7 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.3 | 1.5 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.3 | 0.6 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.3 | 0.6 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 0.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 0.6 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.3 | 0.9 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.3 | 0.9 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 0.3 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.3 | 0.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.3 | 0.3 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.3 | 1.7 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.3 | 8.4 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.3 | 1.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 2.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 2.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 1.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.3 | 1.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.3 | 1.1 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.3 | 0.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 0.6 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.3 | 0.6 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.3 | 0.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.3 | 1.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.3 | 0.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.3 | 0.8 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.3 | 1.1 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.3 | 0.3 | GO:0002118 | aggressive behavior(GO:0002118) |
0.3 | 0.5 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 0.5 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.3 | 1.4 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.3 | 0.5 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.3 | 1.9 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.3 | 1.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.3 | 1.9 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.3 | 0.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.3 | 0.3 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.3 | 0.8 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 1.3 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.3 | 2.4 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.3 | 6.1 | GO:0006813 | potassium ion transport(GO:0006813) |
0.3 | 0.5 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.3 | 0.8 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.3 | 0.5 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.3 | 0.5 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.3 | 0.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.3 | 2.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 0.3 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.3 | 0.5 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.3 | 1.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 0.8 | GO:0042220 | response to cocaine(GO:0042220) |
0.3 | 0.5 | GO:1905049 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.3 | 6.6 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.3 | 0.5 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.3 | 1.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 0.5 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.3 | 0.8 | GO:0007625 | grooming behavior(GO:0007625) |
0.3 | 0.3 | GO:1905216 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.3 | 1.0 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.2 | 0.5 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.2 | 1.7 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 3.2 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 1.2 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 1.9 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 1.9 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.2 | 3.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.2 | 1.2 | GO:0060004 | reflex(GO:0060004) |
0.2 | 3.3 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.2 | 0.5 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.2 | 0.2 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.2 | 0.5 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 0.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.9 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.2 | 0.2 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.2 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.4 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.2 | 0.9 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.2 | 0.2 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.2 | 0.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.4 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.2 | 0.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 1.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.7 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.7 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.2 | 0.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.9 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.2 | 0.6 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.2 | 0.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 0.6 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.2 | 1.3 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.2 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.2 | 0.2 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 0.6 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 0.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 0.4 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 1.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 0.4 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 0.4 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.2 | 0.4 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.2 | 1.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 1.0 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.2 | 0.2 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.2 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.2 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.2 | 0.6 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 1.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.8 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 0.2 | GO:0036475 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
0.2 | 0.2 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.2 | 1.4 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 2.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.2 | 0.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) meiotic cytokinesis(GO:0033206) |
0.2 | 5.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.2 | 0.8 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 2.5 | GO:0032402 | melanosome transport(GO:0032402) |
0.2 | 2.3 | GO:0014044 | Schwann cell development(GO:0014044) |
0.2 | 1.1 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.2 | 0.6 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.2 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.2 | 0.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.2 | 0.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.4 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.2 | 0.7 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 0.5 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.2 | 0.5 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.2 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.4 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.2 | 1.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.2 | 0.7 | GO:0021988 | olfactory lobe development(GO:0021988) |
0.2 | 0.2 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.2 | 0.5 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.2 | 2.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.2 | 1.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.3 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.2 | 0.3 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.2 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 0.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 0.3 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.3 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.2 | 0.3 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.2 | 0.5 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 0.5 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.2 | 0.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 2.1 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.2 | 2.4 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.2 | 0.3 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 0.6 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.3 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.2 | 0.2 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.2 | 0.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 0.9 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
0.2 | 1.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 2.6 | GO:0099518 | vesicle cytoskeletal trafficking(GO:0099518) |
0.2 | 17.8 | GO:0007409 | axonogenesis(GO:0007409) |
0.2 | 0.3 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 1.8 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.2 | 0.9 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.2 | 0.8 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.2 | 0.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 0.2 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.2 | 0.2 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.3 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 0.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.9 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.6 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.4 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.9 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.4 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.1 | 0.6 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.4 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.4 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.3 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.1 | 0.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.4 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.1 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.4 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.3 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.1 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.1 | 0.1 | GO:0048382 | mesendoderm development(GO:0048382) |
0.1 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.6 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.4 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.1 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.1 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 1.0 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 1.0 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.1 | 0.5 | GO:0061525 | hindgut development(GO:0061525) |
0.1 | 0.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.1 | 1.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 1.0 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.1 | 0.3 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.1 | 0.6 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
0.1 | 0.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.6 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.1 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.1 | 0.4 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.2 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.1 | 0.2 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 2.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.6 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.1 | 0.3 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.1 | 0.3 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.5 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.1 | 0.2 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.5 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.3 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 6.3 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
0.1 | 0.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.1 | 0.8 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.1 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 3.0 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.6 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.1 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.5 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.1 | GO:1903416 | response to glycoside(GO:1903416) |
0.1 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.1 | GO:0072610 | interleukin-12 secretion(GO:0072610) |
0.1 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.1 | 0.9 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.1 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.1 | 0.8 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.7 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 4.9 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
0.1 | 0.1 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.1 | 0.2 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.6 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 0.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 0.3 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.2 | GO:0045046 | peroxisomal membrane transport(GO:0015919) peroxisome membrane biogenesis(GO:0016557) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.3 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 0.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.3 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.1 | 0.6 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.7 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.5 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.4 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.1 | 0.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.6 | GO:0045056 | transcytosis(GO:0045056) |
0.1 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.2 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) |
0.1 | 0.2 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.1 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.1 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.1 | 0.5 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.1 | 0.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.1 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.1 | 0.3 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.6 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 0.3 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 0.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.1 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.1 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.1 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.1 | 0.2 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.8 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.7 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0010963 | regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
0.1 | 0.2 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.4 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.4 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.3 | GO:0008347 | glial cell migration(GO:0008347) |
0.0 | 0.3 | GO:0009584 | detection of visible light(GO:0009584) |
0.0 | 0.2 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.0 | GO:0007228 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 0.0 | GO:0070662 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.0 | 0.0 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.0 | 0.5 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.4 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.1 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.0 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.2 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.0 | 0.7 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.0 | 0.0 | GO:0070091 | glucagon secretion(GO:0070091) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.1 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.0 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.1 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.0 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.0 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.1 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 0.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.1 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.0 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.1 | GO:1901524 | regulation of macromitophagy(GO:1901524) negative regulation of mitophagy(GO:1903147) |
0.0 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.2 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.0 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.3 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.0 | GO:0002434 | immune complex clearance(GO:0002434) |
0.0 | 0.0 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.0 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.0 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.0 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
0.0 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.0 | GO:0045168 | cell-cell signaling involved in cell fate commitment(GO:0045168) |
0.0 | 0.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.0 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 1.0 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.0 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.1 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.0 | 0.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.0 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.0 | 1.1 | GO:0019236 | response to pheromone(GO:0019236) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 13.5 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.8 | 52.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
2.7 | 19.1 | GO:0032584 | growth cone membrane(GO:0032584) |
2.5 | 25.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.5 | 29.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
2.4 | 70.6 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
2.3 | 9.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
2.3 | 6.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
2.1 | 12.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
2.1 | 10.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.0 | 23.7 | GO:0043194 | axon initial segment(GO:0043194) |
1.9 | 5.7 | GO:0072534 | perineuronal net(GO:0072534) |
1.9 | 5.7 | GO:0044393 | microspike(GO:0044393) |
1.7 | 12.1 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
1.7 | 1.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.6 | 6.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.6 | 4.9 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.6 | 7.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.5 | 7.5 | GO:0043083 | synaptic cleft(GO:0043083) |
1.5 | 11.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.4 | 8.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
1.4 | 2.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.4 | 4.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.3 | 81.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.3 | 14.7 | GO:0031527 | filopodium membrane(GO:0031527) |
1.2 | 48.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.2 | 12.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.1 | 28.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
1.1 | 18.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.1 | 6.8 | GO:0030673 | axolemma(GO:0030673) |
1.1 | 10.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.1 | 10.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
1.1 | 5.5 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.1 | 3.2 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.1 | 25.5 | GO:0044295 | axonal growth cone(GO:0044295) |
1.0 | 2.9 | GO:0033269 | internode region of axon(GO:0033269) |
1.0 | 1.9 | GO:0033268 | node of Ranvier(GO:0033268) |
1.0 | 1.9 | GO:1990635 | proximal dendrite(GO:1990635) |
0.9 | 0.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.9 | 2.8 | GO:1990696 | USH2 complex(GO:1990696) |
0.9 | 33.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.9 | 12.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.9 | 7.0 | GO:0005883 | neurofilament(GO:0005883) |
0.8 | 114.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.8 | 0.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.8 | 3.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.7 | 2.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.7 | 61.4 | GO:0043204 | perikaryon(GO:0043204) |
0.7 | 2.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.7 | 2.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.7 | 2.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.7 | 0.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 2.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.7 | 2.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.7 | 2.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.7 | 5.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.6 | 1.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.6 | 2.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.6 | 15.7 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.6 | 7.5 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.6 | 1.9 | GO:1990393 | 3M complex(GO:1990393) |
0.6 | 12.7 | GO:0043679 | axon terminus(GO:0043679) |
0.6 | 4.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.6 | 1.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.6 | 1.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.6 | 1.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.6 | 0.6 | GO:0044298 | cell body membrane(GO:0044298) |
0.6 | 5.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 43.1 | GO:0030426 | growth cone(GO:0030426) |
0.5 | 0.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 1.0 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.5 | 22.9 | GO:0043195 | terminal bouton(GO:0043195) |
0.5 | 4.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.5 | 1.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 2.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 1.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 5.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.4 | 2.6 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.4 | 3.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 15.8 | GO:0043197 | dendritic spine(GO:0043197) |
0.4 | 1.7 | GO:1990745 | EARP complex(GO:1990745) |
0.4 | 0.8 | GO:0097441 | basilar dendrite(GO:0097441) |
0.4 | 1.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.4 | 1.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.4 | 1.9 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.4 | 4.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.4 | 1.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 0.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.4 | 7.2 | GO:0005922 | connexon complex(GO:0005922) |
0.4 | 17.1 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.4 | 75.4 | GO:0045202 | synapse(GO:0045202) |
0.3 | 1.0 | GO:0097433 | dense body(GO:0097433) |
0.3 | 4.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 2.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 1.0 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.6 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 3.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 1.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 0.6 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 8.7 | GO:0030175 | filopodium(GO:0030175) |
0.3 | 3.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.3 | 1.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 0.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.3 | 19.2 | GO:0043025 | neuronal cell body(GO:0043025) |
0.3 | 1.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.3 | 1.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 1.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.3 | 1.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.3 | 1.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 0.5 | GO:0030286 | dynein complex(GO:0030286) |
0.3 | 0.5 | GO:0034705 | potassium channel complex(GO:0034705) |
0.3 | 1.3 | GO:0071547 | piP-body(GO:0071547) |
0.3 | 33.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 0.8 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.3 | 0.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.2 | 0.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 0.7 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 1.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 2.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 4.3 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 0.7 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 0.4 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 0.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 0.6 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 0.6 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 3.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 74.7 | GO:0043005 | neuron projection(GO:0043005) |
0.2 | 1.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 0.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 1.9 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 0.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.2 | 4.6 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 0.8 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.4 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.2 | 2.0 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 0.5 | GO:0000802 | transverse filament(GO:0000802) |
0.2 | 1.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.5 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.2 | 0.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.2 | 0.7 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 1.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 0.3 | GO:0000235 | astral microtubule(GO:0000235) |
0.2 | 0.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 3.5 | GO:0016235 | aggresome(GO:0016235) |
0.2 | 1.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.8 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 0.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.6 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 0.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 1.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 1.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 4.8 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 1.4 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 1.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.9 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 1.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 1.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 4.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.5 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.3 | GO:0036396 | MIS complex(GO:0036396) |
0.1 | 0.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.5 | GO:0002177 | manchette(GO:0002177) |
0.1 | 1.0 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 1.0 | GO:0043073 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
0.1 | 2.5 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 1.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.4 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 6.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 2.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 3.2 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.3 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.1 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.5 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 11.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.4 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 1.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.0 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.2 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.0 | 0.0 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 53.4 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.1 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 12.1 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
3.5 | 17.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
3.4 | 10.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
3.3 | 13.3 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
3.0 | 9.1 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
2.8 | 11.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.8 | 25.4 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
2.7 | 8.0 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.6 | 20.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
2.4 | 9.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.4 | 7.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
2.4 | 7.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
2.4 | 14.1 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
2.2 | 6.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.1 | 15.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
2.1 | 6.4 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.0 | 12.0 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
2.0 | 13.9 | GO:0003680 | AT DNA binding(GO:0003680) |
2.0 | 5.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.9 | 20.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.9 | 9.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.8 | 7.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.8 | 7.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.8 | 5.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.8 | 1.8 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.8 | 3.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
1.6 | 9.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.6 | 7.9 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.6 | 3.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
1.6 | 3.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.5 | 4.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.5 | 6.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.5 | 6.0 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.5 | 7.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.5 | 7.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.4 | 8.6 | GO:0048495 | Roundabout binding(GO:0048495) |
1.4 | 11.4 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.4 | 7.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.4 | 4.2 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.4 | 5.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.4 | 5.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.4 | 4.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.3 | 4.0 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
1.3 | 5.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
1.3 | 8.9 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
1.3 | 5.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.3 | 12.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.3 | 3.8 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.2 | 13.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.2 | 1.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
1.2 | 3.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.2 | 23.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.2 | 7.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.2 | 13.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.2 | 2.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.2 | 3.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
1.2 | 2.3 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
1.2 | 11.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.2 | 3.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
1.1 | 4.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.1 | 5.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.1 | 3.3 | GO:0034936 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
1.1 | 4.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.1 | 5.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.1 | 15.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.0 | 31.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.0 | 8.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.0 | 3.0 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
1.0 | 1.0 | GO:0038191 | neuropilin binding(GO:0038191) |
1.0 | 3.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.0 | 3.9 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.0 | 20.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.0 | 4.9 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.0 | 4.9 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
1.0 | 2.9 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.0 | 8.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.0 | 1.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.0 | 13.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.0 | 2.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.0 | 2.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.9 | 3.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.9 | 21.9 | GO:0005272 | sodium channel activity(GO:0005272) |
0.9 | 10.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.9 | 23.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.9 | 3.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.9 | 2.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.9 | 2.7 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.9 | 20.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.9 | 9.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.9 | 3.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.8 | 3.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.8 | 0.8 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.8 | 28.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.8 | 4.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.8 | 10.8 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.8 | 9.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.8 | 0.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.8 | 1.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.8 | 4.0 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.8 | 3.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.8 | 9.4 | GO:0031005 | filamin binding(GO:0031005) |
0.8 | 0.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.7 | 3.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.7 | 13.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.7 | 2.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.7 | 17.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.7 | 8.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.7 | 2.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.7 | 3.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.7 | 5.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.7 | 4.9 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.7 | 0.7 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.7 | 8.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.7 | 3.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.7 | 2.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.7 | 16.2 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.7 | 24.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.7 | 2.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.7 | 12.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.7 | 1.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.7 | 2.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.7 | 4.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.7 | 2.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.6 | 2.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.6 | 1.9 | GO:0035939 | microsatellite binding(GO:0035939) |
0.6 | 7.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.6 | 18.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.6 | 1.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.6 | 2.5 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.6 | 2.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.6 | 2.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.6 | 4.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.6 | 1.2 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.6 | 0.6 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.6 | 2.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.6 | 2.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.6 | 14.1 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.6 | 6.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.6 | 13.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.6 | 14.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.6 | 2.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.6 | 2.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.6 | 5.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.6 | 3.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.6 | 6.1 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.6 | 1.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.6 | 2.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.5 | 1.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.5 | 13.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.5 | 1.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.5 | 9.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.5 | 3.2 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.5 | 5.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 1.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.5 | 1.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.5 | 3.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.5 | 1.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.5 | 1.5 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.5 | 14.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.5 | 1.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.5 | 1.5 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.5 | 4.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.5 | 7.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 1.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.5 | 2.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.5 | 6.3 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.5 | 6.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.5 | 8.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.5 | 1.9 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 4.3 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.5 | 8.6 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 1.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 3.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.5 | 6.5 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.5 | 13.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 10.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.5 | 1.4 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.5 | 6.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.5 | 1.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.5 | 2.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 3.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.4 | 2.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.4 | 1.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.4 | 2.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 0.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 5.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 1.3 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.4 | 3.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 2.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.4 | 1.7 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.4 | 0.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.4 | 2.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 2.1 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.4 | 1.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 0.4 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.4 | 0.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 10.0 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.4 | 1.2 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.4 | 4.1 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 17.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.4 | 2.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.4 | 2.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.4 | 1.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.4 | 4.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.4 | 1.9 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.4 | 4.6 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.4 | 0.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 3.1 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.4 | 1.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.4 | 1.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.4 | 1.5 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.4 | 2.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 1.1 | GO:0030519 | snoRNP binding(GO:0030519) |
0.4 | 0.4 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.4 | 1.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 0.4 | GO:0097001 | ceramide binding(GO:0097001) |
0.4 | 0.4 | GO:0016775 | phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.4 | 9.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.4 | 2.1 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 2.4 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.3 | 1.0 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 3.1 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.3 | 3.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 3.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 2.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 1.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.3 | 1.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 0.6 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 4.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 1.9 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 1.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 0.9 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 7.0 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 0.3 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.3 | 7.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.3 | 15.5 | GO:0019905 | syntaxin binding(GO:0019905) |
0.3 | 1.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 3.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 4.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 0.9 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 1.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 1.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 1.8 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.3 | 1.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 1.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 1.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 0.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 0.6 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.3 | 0.6 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.3 | 4.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 1.9 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.3 | 2.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 1.6 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 0.8 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.3 | 0.8 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 0.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.3 | 0.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.3 | 0.8 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 6.0 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.2 | 1.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 3.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 3.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 2.4 | GO:0052769 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.2 | 1.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 1.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 1.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 1.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.2 | 0.9 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.5 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 22.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 3.9 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.9 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.2 | 0.9 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 1.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 1.1 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 1.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 0.4 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 1.5 | GO:0034791 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 0.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 90.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 0.4 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.2 | 1.0 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 0.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 5.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 1.8 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.2 | 2.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 3.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 0.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 1.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 0.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 1.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.8 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 1.4 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.6 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 0.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 0.8 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 3.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 4.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.2 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 2.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 2.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 0.5 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 1.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.7 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 0.5 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 0.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.3 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.8 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 4.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.2 | 0.3 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.2 | 2.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 1.6 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.2 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.2 | 2.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 8.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.1 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 0.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 1.5 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 5.4 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 1.7 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 3.7 | GO:0018602 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 0.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 3.5 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.3 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 1.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.4 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 1.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 1.2 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 1.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 2.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 1.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 0.2 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.1 | 0.2 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.6 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.5 | GO:0030594 | neurotransmitter receptor activity(GO:0030594) |
0.1 | 0.2 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 3.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 2.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
0.1 | 0.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.1 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.3 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 1.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.3 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.4 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 2.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.3 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 0.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 1.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 1.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 12.4 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 2.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 13.3 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 1.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 0.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 1.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.1 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.1 | 0.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 0.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 1.1 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 3.8 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 2.8 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.1 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.4 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.6 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 2.0 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.5 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.0 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.0 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.0 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.1 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.0 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 15.8 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.0 | GO:0034857 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.0 | 0.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.0 | 0.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.0 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.2 | GO:0019177 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.0 | 0.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.0 | GO:0030911 | TPR domain binding(GO:0030911) |
0.0 | 0.0 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.0 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 0.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 1.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.9 | 12.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.8 | 1.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.8 | 11.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.7 | 21.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.7 | 16.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.7 | 11.8 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.7 | 18.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.6 | 7.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.6 | 8.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.6 | 2.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.6 | 27.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.6 | 16.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.6 | 2.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.6 | 14.9 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.5 | 15.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 4.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 6.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 8.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 10.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 50.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 1.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 10.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 4.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 5.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 2.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 0.5 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 5.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 10.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 8.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 2.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 24.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 1.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 20.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 2.2 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.2 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 1.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.8 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 4.7 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
2.5 | 37.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.2 | 30.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
1.9 | 18.9 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.7 | 23.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.6 | 32.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.6 | 1.6 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
1.5 | 15.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
1.3 | 14.3 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.2 | 53.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.2 | 1.2 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
1.1 | 26.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.1 | 12.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.1 | 9.9 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
1.1 | 26.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.1 | 12.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.0 | 9.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.0 | 10.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.0 | 24.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.9 | 16.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.8 | 13.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.8 | 15.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.8 | 0.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.7 | 5.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.7 | 8.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.6 | 4.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.6 | 26.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.6 | 4.5 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.6 | 1.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.6 | 6.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.6 | 8.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.6 | 2.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.6 | 8.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.6 | 1.7 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.6 | 6.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 7.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.5 | 5.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.5 | 24.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.5 | 3.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.5 | 4.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.5 | 9.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 7.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.4 | 6.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.4 | 13.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.4 | 6.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.4 | 6.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 8.5 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 59.8 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.4 | 2.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 7.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 2.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 5.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 1.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.3 | 2.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 5.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.3 | 3.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 0.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 2.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 1.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 4.2 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 0.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 1.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 0.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 0.2 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 4.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 1.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 0.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 0.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 1.5 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.2 | 1.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 5.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 1.0 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.2 | 1.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 1.8 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 3.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 0.2 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 0.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 0.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 0.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 2.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.5 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 0.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.8 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 1.2 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 1.8 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 1.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |